Related Experiment Video
Updated: Dec 24, 2025
07:31
Image Acquisition using Portable Sonography for Emergency Airway Management
Published on: September 28, 2022
2.8K
General Pediatric Clinical Applications of POCUS: Part 2.
Pediatric Annals
|April 11, 2020
Summary
Pediatricians can use point-of-care ultrasound (POCUS) in various clinical settings. This review covers 10 POCUS applications beneficial for children, offering a radiation-free diagnostic alternative.
Area of Science:
- Pediatric Medicine
- Medical Imaging
- Point-of-Care Diagnostics
Background:
- Point-of-care ultrasound (POCUS) use is expanding in pediatrics.
- Children are more susceptible to radiation risks than adults.
- POCUS offers a safe, effective imaging modality for pediatric patients.
Purpose of the Study:
- To review 10 practical applications of POCUS for pediatricians.
- To highlight POCUS utility in both inpatient and outpatient pediatric care.
- To support the integration of POCUS into pediatric practice.
Main Methods:
- Review of existing literature and clinical guidelines on POCUS in pediatrics.
- Identification of 10 key POCUS applications relevant to pediatricians.
- Discussion of POCUS implementation in diverse pediatric settings.
Main Results:
- POCUS can be effectively used by non-radiologists in pediatric care.
- The article details 10 specific POCUS applications for pediatricians.
- POCUS provides valuable diagnostic information across various pediatric conditions.
Conclusions:
- POCUS is a valuable tool for pediatricians, enhancing diagnostic capabilities.
- The adoption of POCUS in pediatrics offers a safer alternative to radiation-based imaging.
- Expanding POCUS use can improve pediatric patient care and outcomes.
More Related Videos
08:22The Application of Point-of-Care Ultrasonography (POCUS) in the Management of Acute Respiratory Distress Syndrome (ARDS) in the Intensive Care Unit
Published on: December 12, 2025
309
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
51.7K
Related Concept Videos
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
176
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
176
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
194
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
194
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
150
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
150
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
134
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
134
01:26Methods of Documentation II: POMR
1.3K
The Problem-Oriented Medical Record (POMR) revolutionized medical record-keeping by introducing a systematic approach focusing on the patient's problems rather than merely listing symptoms. Dr. Lawrence Weed's introduction of this method in the 1960s marked a significant advancement in medical documentation. The POMR framework consists of four key components: the database, problem list, plan of care, and progress notes.
1.3K
01:29Drug Dosing: Infants and Children
178
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
178